- call +1-201-465-4211
- email sales@mrinsights.biz
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.
Scope of the Report:
The Global Advanced Drug Delivery Market is poised to grow at a CAGR of around 7.8% over the next decade to reach approximately $340 billion by 2025. Some of the prominent trends that the market is witnessing include growing focus on unmet medical requirements, increasing demand for generic drugs and biosimilars, rising familiarities of chronic diseases and recent technological developments of advanced drug delivery.
Based on technology, the market is categorized into polymeric drug delivery, implants & IUD's, sustained release, targeted drug delivery and prodrugs. By polymeric drug delivery, the market is further divided into nebulizers, metered dose inhalers and dry powder inhalers.
By end user, the market is segregated into hospitals, diagnostic centers, ambulatory surgical centers/clinics, home care settings and other end users.
The global Advanced Drug Delivery market is valued at 340 million USD in 2017 and is expected to reach 520 million USD by the end of 2023, growing at a CAGR of 7.5% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Advanced Drug Delivery.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Advanced Drug Delivery market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Advanced Drug Delivery market by product type and applications/end industries.
Market Segment by Companies, this report covers
Merck & Co
Antares Pharma
F. Hoffmann-La Roche
Novartis
Bayer
Sanofi
Glaxosmithkline
3M
Pfizer
Johnson & Johnson
Abbott Laboratories
Allergan
Baxter International
Mylan Pharmaceutical
Roche Holding
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Polymeric Drug Delivery
Implants & IUD's
Sustained Release
Targeted Drug Delivery
Prodrugs
Market Segment by Applications, can be divided into
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers/Clinics
Home Care Settings
Other End Users
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Advanced Drug Delivery Market Overview
1.1 Product Overview and Scope of Advanced Drug Delivery
1.2 Classification of Advanced Drug Delivery by Types
1.2.1 Global Advanced Drug Delivery Revenue Comparison by Types (2017-2023)
1.2.2 Global Advanced Drug Delivery Revenue Market Share by Types in 2017
1.2.3 Polymeric Drug Delivery
1.2.4 Implants & IUD's
1.2.5 Sustained Release
1.2.6 Targeted Drug Delivery
1.2.7 Prodrugs
1.3 Global Advanced Drug Delivery Market by Application
1.3.1 Global Advanced Drug Delivery Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Ambulatory Surgical Centers/Clinics
1.3.5 Home Care Settings
1.3.6 Other End Users
1.4 Global Advanced Drug Delivery Market by Regions
1.4.1 Global Advanced Drug Delivery Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Advanced Drug Delivery Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Advanced Drug Delivery Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Advanced Drug Delivery Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Advanced Drug Delivery Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Advanced Drug Delivery Status and Prospect (2013-2023)
1.5 Global Market Size of Advanced Drug Delivery (2013-2023)
2 Manufacturers Profiles
2.1 Merck & Co
2.1.1 Business Overview
2.1.2 Advanced Drug Delivery Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck & Co Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.2 Antares Pharma
2.2.1 Business Overview
2.2.2 Advanced Drug Delivery Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Antares Pharma Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann-La Roche
2.3.1 Business Overview
2.3.2 Advanced Drug Delivery Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Advanced Drug Delivery Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bayer
2.5.1 Business Overview
2.5.2 Advanced Drug Delivery Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bayer Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Advanced Drug Delivery Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.7 Glaxosmithkline
2.7.1 Business Overview
2.7.2 Advanced Drug Delivery Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Glaxosmithkline Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.8 3M
2.8.1 Business Overview
2.8.2 Advanced Drug Delivery Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 3M Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Advanced Drug Delivery Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.2 Advanced Drug Delivery Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson & Johnson Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.11 Abbott Laboratories
2.11.1 Business Overview
2.11.2 Advanced Drug Delivery Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Abbott Laboratories Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.12 Allergan
2.12.1 Business Overview
2.12.2 Advanced Drug Delivery Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Allergan Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.13 Baxter International
2.13.1 Business Overview
2.13.2 Advanced Drug Delivery Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Baxter International Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.14 Mylan Pharmaceutical
2.14.1 Business Overview
2.14.2 Advanced Drug Delivery Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Mylan Pharmaceutical Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.15 Roche Holding
2.15.1 Business Overview
2.15.2 Advanced Drug Delivery Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Roche Holding Advanced Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
3 Global Advanced Drug Delivery Market Competition, by Players
3.1 Global Advanced Drug Delivery Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Advanced Drug Delivery Players Market Share
3.2.2 Top 10 Advanced Drug Delivery Players Market Share
3.3 Market Competition Trend
4 Global Advanced Drug Delivery Market Size by Regions
4.1 Global Advanced Drug Delivery Revenue and Market Share by Regions
4.2 North America Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
4.3 Europe Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
4.5 South America Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
5 North America Advanced Drug Delivery Revenue by Countries
5.1 North America Advanced Drug Delivery Revenue by Countries (2013-2018)
5.2 USA Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
5.3 Canada Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
5.4 Mexico Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
6 Europe Advanced Drug Delivery Revenue by Countries
6.1 Europe Advanced Drug Delivery Revenue by Countries (2013-2018)
6.2 Germany Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
6.3 UK Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
6.4 France Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
6.5 Russia Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
6.6 Italy Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Advanced Drug Delivery Revenue by Countries
7.1 Asia-Pacific Advanced Drug Delivery Revenue by Countries (2013-2018)
7.2 China Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
7.3 Japan Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
7.4 Korea Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
7.5 India Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
8 South America Advanced Drug Delivery Revenue by Countries
8.1 South America Advanced Drug Delivery Revenue by Countries (2013-2018)
8.2 Brazil Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
8.3 Argentina Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
8.4 Colombia Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Advanced Drug Delivery by Countries
9.1 Middle East and Africa Advanced Drug Delivery Revenue by Countries (2013-2018)
9.2 Saudi Arabia Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
9.3 UAE Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
9.4 Egypt Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
9.5 Nigeria Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
9.6 South Africa Advanced Drug Delivery Revenue and Growth Rate (2013-2018)
10 Global Advanced Drug Delivery Market Segment by Type
10.1 Global Advanced Drug Delivery Revenue and Market Share by Type (2013-2018)
10.2 Global Advanced Drug Delivery Market Forecast by Type (2018-2023)
10.3 Polymeric Drug Delivery Revenue Growth Rate (2013-2023)
10.4 Implants & IUD's Revenue Growth Rate (2013-2023)
10.5 Sustained Release Revenue Growth Rate (2013-2023)
10.6 Targeted Drug Delivery Revenue Growth Rate (2013-2023)
10.7 Prodrugs Revenue Growth Rate (2013-2023)
11 Global Advanced Drug Delivery Market Segment by Application
11.1 Global Advanced Drug Delivery Revenue Market Share by Application (2013-2018)
11.2 Advanced Drug Delivery Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Diagnostic Centers Revenue Growth (2013-2018)
11.5 Ambulatory Surgical Centers/Clinics Revenue Growth (2013-2018)
11.6 Home Care Settings Revenue Growth (2013-2018)
11.7 Other End Users Revenue Growth (2013-2018)
12 Global Advanced Drug Delivery Market Size Forecast (2018-2023)
12.1 Global Advanced Drug Delivery Market Size Forecast (2018-2023)
12.2 Global Advanced Drug Delivery Market Forecast by Regions (2018-2023)
12.3 North America Advanced Drug Delivery Revenue Market Forecast (2018-2023)
12.4 Europe Advanced Drug Delivery Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Advanced Drug Delivery Revenue Market Forecast (2018-2023)
12.6 South America Advanced Drug Delivery Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Advanced Drug Delivery Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Advanced Drug Delivery Picture
Table Product Specifications of Advanced Drug Delivery
Table Global Advanced Drug Delivery and Revenue (Million USD) Market Split by P
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
